Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tissue factor and thrombosis: The clot starts here.

Literature DB >> 20539911

Tissue factor and thrombosis: The clot starts here.

Abstract

Thrombosis, or complications from thrombosis, currently occupies the top three positions in the cardiovascular causes of morbidity and mortality in the developed world. There are a limited number of safe and effective drugs to prevent and treat thrombosis. Animal models of thrombosis are necessary to better understand the complex components and interactions involved in the formation of a clot. Tissue factor (TF) is required for the initiation of blood coagulation and likely plays a key role in both arterial and venous thrombosis. Understanding the role of TF in thrombosis may permit the development of new antithrombotic drugs. This review will focus on the role of TF in in vivo models of thrombosis.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2010 PMID： 20539911 PMCID： PMC3043984 DOI： 10.1160/TH09-11-0771

Source DB: PubMed Journal: Thromb Haemost ISSN： 0340-6245 Impact factor: 5.249

92 in total

1. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody.

Authors: R A Fleck; L V Rao; S I Rapaport; N Varki
Journal: Thromb Res Date: 1990-07-15 Impact factor: 3.944

2. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation.

Authors: T H Bugge; Q Xiao; K W Kombrinck; M J Flick; K Holmbäck; M J Danton; M C Colbert; D P Witte; K Fujikawa; E W Davie; J L Degen
Journal: Proc Natl Acad Sci U S A Date: 1996-06-25 Impact factor: 11.205

3. Photodynamic retinal vascular thrombosis. Rate and duration of vascular occlusion.

Authors: C A Wilson; D L Hatchell
Journal: Invest Ophthalmol Vis Sci Date: 1991-07 Impact factor: 4.799

Review 4. The structural biology of expression and function of tissue factor.

Authors: T S Edgington; N Mackman; K Brand; W Ruf
Journal: Thromb Haemost Date: 1991-07-12 Impact factor: 5.249

5. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity.

Authors: T A Warr; L V Rao; S I Rapaport
Journal: Blood Date: 1990-04-01 Impact factor: 22.113

6. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

Authors: T A Drake; J H Morrissey; T S Edgington
Journal: Am J Pathol Date: 1989-05 Impact factor: 4.307

7. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.

Authors: F B Taylor; A Chang; W Ruf; J H Morrissey; L Hinshaw; R Catlett; K Blick; T S Edgington
Journal: Circ Shock Date: 1991-03

8. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.

Authors: S J van Deventer; H R Büller; J W ten Cate; L A Aarden; C E Hack; A Sturk
Journal: Blood Date: 1990-12-15 Impact factor: 22.113

9. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.

Authors: M Shimura; H Wada; Y Wakita; T Nakase; K Hiyoyama; S Nagaya; Y Mori; H Shiku
Journal: Am J Hematol Date: 1996-07 Impact factor: 10.047

10. Activation of coagulation after administration of tumor necrosis factor to normal subjects.

Authors: T van der Poll; H R Büller; H ten Cate; C H Wortel; K A Bauer; S J van Deventer; C E Hack; H P Sauerwein; R D Rosenberg; J W ten Cate
Journal: N Engl J Med Date: 1990-06-07 Impact factor: 91.245

51 in total

1. Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.

Authors: Daria B Crittenden; R Aaron Lehmann; Laura Schneck; Robert T Keenan; Binita Shah; Jeffrey D Greenberg; Bruce N Cronstein; Steven P Sedlis; Michael H Pillinger
Journal: J Rheumatol Date: 2012-06-01 Impact factor: 4.666

2. Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease.

Authors: Weihong Tang; Christine Schwienbacher; Lorna M Lopez; Yoav Ben-Shlomo; Tiphaine Oudot-Mellakh; Andrew D Johnson; Nilesh J Samani; Saonli Basu; Martin Gögele; Gail Davies; Gordon D O Lowe; David-Alexandre Tregouet; Adrian Tan; James S Pankow; Albert Tenesa; Daniel Levy; Claudia B Volpato; Ann Rumley; Alan J Gow; Cosetta Minelli; John W G Yarnell; David J Porteous; John M Starr; John Gallacher; Eric Boerwinkle; Peter M Visscher; Peter P Pramstaller; Mary Cushman; Valur Emilsson; Andrew S Plump; Nena Matijevic; Pierre-Emmanuel Morange; Ian J Deary; Andrew A Hicks; Aaron R Folsom
Journal: Am J Hum Genet Date: 2012-06-14 Impact factor: 11.025

3. Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.

Authors: Zachary M Huttinger; Michael W Milks; Michael S Nickoli; William L Aurand; Lawrence C Long; Debra G Wheeler; Karen M Dwyer; Anthony J F d'Apice; Simon C Robson; Peter J Cowan; Richard J Gumina
Journal: Am J Pathol Date: 2012-05-18 Impact factor: 4.307

Tissue factor and thrombosis: The clot starts here.

1. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody.

2. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation.

3. Photodynamic retinal vascular thrombosis. Rate and duration of vascular occlusion.

Review 4. The structural biology of expression and function of tissue factor.

5. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity.

6. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

7. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.

8. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.

9. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.

10. Activation of coagulation after administration of tumor necrosis factor to normal subjects.

1. Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.

2. Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease.

3. Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.

Review 4. The Intrinsic Pathway of Coagulation as a Target for Antithrombotic Therapy.

Review 5. Sources of tissue factor that contribute to thrombosis after rupture of an atherosclerotic plaque.

Review 6. Factor XI and contact activation as targets for antithrombotic therapy.

7. Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis.

Review 8. Bioengineered in vitro models of thrombosis: methods and techniques.

Review 9. New players in haemostasis and thrombosis.

Review 10. Role of tissue factor in atherothrombosis.